Hígado graso no alcohólico en consulta de gastroenterología

Autores:: Ochoa C., Edwin
Calambás, Fredy

Tipo de recurso:: Article of journal

Fecha de publicación:: 2017

Institución:: Fundación Universitaria de Ciencias de la Salud - FUCS

Repositorio:: Repositorio Digital Institucional ReDi

Idioma:: spa

id	FUCS2_4737c3e3c4197c85c19e197d04f1a9da
oai_identifier_str	oai:repositorio.fucsalud.edu.co:001/2035
network_acronym_str	FUCS2
network_name_str	Repositorio Digital Institucional ReDi
repository_id_str
dc.title.spa.fl_str_mv	Hígado graso no alcohólico en consulta de gastroenterología
dc.title.translated.eng.fl_str_mv	Nonalcoholic fatty liver disease at the gastroenterology outpatient clinic
title	Hígado graso no alcohólico en consulta de gastroenterología
spellingShingle	Hígado graso no alcohólico en consulta de gastroenterología Hígado graso Factores de riesgo NASH NAFLD Esteatosis hepática Cirrosis Fatty liver Risk factors NASH NAFLD Hepatic steatosis Cirrhosis
title_short	Hígado graso no alcohólico en consulta de gastroenterología
title_full	Hígado graso no alcohólico en consulta de gastroenterología
title_fullStr	Hígado graso no alcohólico en consulta de gastroenterología
title_full_unstemmed	Hígado graso no alcohólico en consulta de gastroenterología
title_sort	Hígado graso no alcohólico en consulta de gastroenterología
dc.creator.fl_str_mv	Ochoa C., Edwin Calambás, Fredy
dc.contributor.author.spa.fl_str_mv	Ochoa C., Edwin Calambás, Fredy
dc.subject.spa.fl_str_mv	Hígado graso Factores de riesgo NASH NAFLD Esteatosis hepática Cirrosis
topic	Hígado graso Factores de riesgo NASH NAFLD Esteatosis hepática Cirrosis Fatty liver Risk factors NASH NAFLD Hepatic steatosis Cirrhosis
dc.subject.eng.fl_str_mv	Fatty liver Risk factors NASH NAFLD Hepatic steatosis Cirrhosis
publishDate	2017
dc.date.accessioned.none.fl_str_mv	2017-12-01 00:00:00 2022-02-21T20:33:27Z
dc.date.issued.none.fl_str_mv	2017-12-01
dc.date.available.none.fl_str_mv	2017-12-01 00:00:00 2022-02-21T20:33:27Z
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.eng.fl_str_mv	Journal article
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.spa.fl_str_mv	http://purl.org/coar/resource_type/c_6501
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.content.spa.fl_str_mv	Text
dc.type.coarversion.spa.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
format	http://purl.org/coar/resource_type/c_6501
status_str	publishedVersion
dc.identifier.issn.none.fl_str_mv	0121-7372
dc.identifier.uri.none.fl_str_mv	https://repositorio.fucsalud.edu.co/handle/001/2035
dc.identifier.eissn.none.fl_str_mv	2462-991X
dc.identifier.url.none.fl_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/56
identifier_str_mv	0121-7372 2462-991X
url	https://repositorio.fucsalud.edu.co/handle/001/2035 https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/56
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.references.spa.fl_str_mv	Beltrán Galvis OA, Galindo A, Mendoza Y, Hernández G, Varón A, Garzón MA, et al. Guía de práctica clínica para la enfermedad hepática grasa no alcohólica. Rev Col Gastroenterol. 2015;30 Supl 1:89–96. Lall CG, Aisen AM, Bansal N, Sandrasegaran K. Nonalcoholic fatty liver disease. AJR Am J Roentgenol. 2008;190:993–1002. Bayard M, Holt J, Boroughs E. Nonalcoholic fatty liver disease. Am Fam Physician. 2006;73:1961–8. Guía de práctica clínica. Diagnóstico y tratamiento de la enfermedad hepática grasa no alcohólica del adulto. México, D. F.: Secretaría de Salud; 2014. DOI: IMSS-719-14. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology. 2006;43 2 Suppl 1:S99–112. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al., American Gastroenterological Association; American Association for the Study of Liver Diseases; American College of Gastroenterology. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142:1592–609. Sanyal AJ, American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;123:1705–25. Musso G, Gambino R, Cassader M, Pagano G. Metaanalysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011;43:617–49. Kwok R, Tse YK, Wong GL, Ha Y, Lee AU, Ngu MC, et al. Systematic review with meta-analysis: Noninvasive assessment of non-alcoholic fatty liver disease-The role of transient elastography and plasma cytokeratin-18 fragments. Aliment Pharmacol Ther. 2014;39:254–69. Ratziu V, Harrison SA, Francque S, Bedossa P, Lehert P, Serfaty L, et al. Elafibranor, an agonist of the peroxisome proliferator-activated receptor-␣ and -␦, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening. Gastroenterology. 2016;150, 1147.e5-1159.e5. Ratziu V, Harrison SA, Francque S, Bedossa P, Lehert P, Serfaty L, et al. GOLDEN-505 Investigator Study Group. Phase 3 study to evaluate the efficacy and safety of elafibranor versus placebo in patients with nonalcoholic steatohepatitis (NASH) (RESOLVE-IT). NCT02704403. 2017. Keating SE, Hackett DA, George J, Johnson NA. Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis. J Hepatol. 2012;57:157–66. Thoma C, Day CP, Trenell MI. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review. J Hepatol. 2012;56:255–66. Zelber-Sagi S, Salomone F, Webb M, Lotan R, Yeshua H, Halpern Z, et al. Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population. Transl Res. 2015;165:428–36. Wang X, Li J, Riaz DR, Shi G, Liu C, Dai Y. Outcomes of liver transplantation for nonalcoholic steatohepatitis: A systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12:394–402. Prieto Ortiz J, Sánchez Pardo S, Rojas Díaz L, Huertas Pacheco S. Hígado graso: aspectos clínicos en un centro de tercer nivel en Bogotá - período 2009-2013. Rev Col Gastroenterol. 2014;29:117–24. Vanegas CM, Restrepo C, Vargas N, Marín AE, Martínez LM, Yepes CE, et al. Caracterización de pacientes con enfermedad del hígado graso no alcohólica en un hospital de alta complejidad, Colombia 2013. Rev Col Gastroenterol. 2014;29:342–6. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140:124–31. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55:434. Lee RG. Nonalcoholic steatohepatitis: A study of 49 patients. Hum Pathol. 1989;20:594. Vernon G, Baranova A, Younossi ZM. Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34:274.
dc.relation.bitstream.none.fl_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/56/45
dc.relation.citationedition.spa.fl_str_mv	Núm. 4 , Año 2017 : Octubre – Diciembre
dc.relation.citationendpage.none.fl_str_mv	230
dc.relation.citationissue.spa.fl_str_mv	4
dc.relation.citationstartpage.none.fl_str_mv	225
dc.relation.citationvolume.spa.fl_str_mv	26
dc.relation.ispartofjournal.spa.fl_str_mv	Revista Repertorio de Medicina y Cirugía
dc.rights.spa.fl_str_mv	Fundación Universitaria de Ciencias de la Salud-FUCS - 2017
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
dc.rights.uri.spa.fl_str_mv	https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.coar.spa.fl_str_mv	http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv	Fundación Universitaria de Ciencias de la Salud-FUCS - 2017 https://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
dc.source.spa.fl_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/56
institution	Fundación Universitaria de Ciencias de la Salud - FUCS
bitstream.url.fl_str_mv	https://repositorio.fucsalud.edu.co/bitstreams/7a91b4ab-7369-486f-89fb-aebb0997a512/download
bitstream.checksum.fl_str_mv	ab44111450fa6ff1fef3c6f9cf3ef3b0
bitstream.checksumAlgorithm.fl_str_mv	MD5
repository.name.fl_str_mv	Repositorio Digital de la Fundación Universitaria de Ciencias de la Salud
repository.mail.fl_str_mv	redi@fucsalud.edu.co
_version_	1814355558428311552
spelling	Ochoa C., Edwin52a7765364a8982bf8f9cbc991a9fcf2300Calambás, Fredy56dd06bfdc932ffccbd7c3004ae3ff683002017-12-01 00:00:002022-02-21T20:33:27Z2017-12-012017-12-01 00:00:002022-02-21T20:33:27ZSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la SaludFundación Universitaria de Ciencias de la Salud-FUCS - 2017info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/56Hígado grasoFactores de riesgoNASHNAFLDEsteatosis hepáticaCirrosisFatty liverRisk factorsNASHNAFLDHepatic steatosisCirrhosisHígado graso no alcohólico en consulta de gastroenterologíaNonalcoholic fatty liver disease at the gastroenterology outpatient clinicapplication/pdfArtículo de revistaJournal articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/coar/version/c_970fb48d4fbd8a850121-7372https://repositorio.fucsalud.edu.co/handle/001/20352462-991Xhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/view/56spaBeltrán Galvis OA, Galindo A, Mendoza Y, Hernández G, Varón A, Garzón MA, et al. Guía de práctica clínica para la enfermedad hepática grasa no alcohólica. Rev Col Gastroenterol. 2015;30 Supl 1:89–96.Lall CG, Aisen AM, Bansal N, Sandrasegaran K. Nonalcoholic fatty liver disease. AJR Am J Roentgenol. 2008;190:993–1002.Bayard M, Holt J, Boroughs E. Nonalcoholic fatty liver disease. Am Fam Physician. 2006;73:1961–8.Guía de práctica clínica. Diagnóstico y tratamiento de la enfermedad hepática grasa no alcohólica del adulto. México, D. F.: Secretaría de Salud; 2014. DOI: IMSS-719-14.Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology. 2006;43 2 Suppl 1:S99–112.Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al., American Gastroenterological Association; American Association for the Study of Liver Diseases; American College of Gastroenterology. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142:1592–609.Sanyal AJ, American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;123:1705–25.Musso G, Gambino R, Cassader M, Pagano G. Metaanalysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011;43:617–49.Kwok R, Tse YK, Wong GL, Ha Y, Lee AU, Ngu MC, et al. Systematic review with meta-analysis: Noninvasive assessment of non-alcoholic fatty liver disease-The role of transient elastography and plasma cytokeratin-18 fragments. Aliment Pharmacol Ther. 2014;39:254–69.Ratziu V, Harrison SA, Francque S, Bedossa P, Lehert P, Serfaty L, et al. Elafibranor, an agonist of the peroxisome proliferator-activated receptor-␣ and -␦, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening. Gastroenterology. 2016;150, 1147.e5-1159.e5.Ratziu V, Harrison SA, Francque S, Bedossa P, Lehert P, Serfaty L, et al. GOLDEN-505 Investigator Study Group. Phase 3 study to evaluate the efficacy and safety of elafibranor versus placebo in patients with nonalcoholic steatohepatitis (NASH) (RESOLVE-IT). NCT02704403. 2017.Keating SE, Hackett DA, George J, Johnson NA. Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis. J Hepatol. 2012;57:157–66.Thoma C, Day CP, Trenell MI. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review. J Hepatol. 2012;56:255–66.Zelber-Sagi S, Salomone F, Webb M, Lotan R, Yeshua H, Halpern Z, et al. Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population. Transl Res. 2015;165:428–36.Wang X, Li J, Riaz DR, Shi G, Liu C, Dai Y. Outcomes of liver transplantation for nonalcoholic steatohepatitis: A systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12:394–402.Prieto Ortiz J, Sánchez Pardo S, Rojas Díaz L, Huertas Pacheco S. Hígado graso: aspectos clínicos en un centro de tercer nivel en Bogotá - período 2009-2013. Rev Col Gastroenterol. 2014;29:117–24.Vanegas CM, Restrepo C, Vargas N, Marín AE, Martínez LM, Yepes CE, et al. Caracterización de pacientes con enfermedad del hígado graso no alcohólica en un hospital de alta complejidad, Colombia 2013. Rev Col Gastroenterol. 2014;29:342–6.Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140:124–31.Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55:434.Lee RG. Nonalcoholic steatohepatitis: A study of 49 patients. Hum Pathol. 1989;20:594.Vernon G, Baranova A, Younossi ZM. Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34:274.https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/56/45Núm. 4 , Año 2017 : Octubre – Diciembre230422526Revista Repertorio de Medicina y CirugíaPublicationOREORE.xmltext/xml2512https://repositorio.fucsalud.edu.co/bitstreams/7a91b4ab-7369-486f-89fb-aebb0997a512/downloadab44111450fa6ff1fef3c6f9cf3ef3b0MD51001/2035oai:repositorio.fucsalud.edu.co:001/20352024-02-02 13:09:53.382https://creativecommons.org/licenses/by-nc-sa/4.0/Fundación Universitaria de Ciencias de la Salud-FUCS - 2017metadata.onlyhttps://repositorio.fucsalud.edu.coRepositorio Digital de la Fundación Universitaria de Ciencias de la Saludredi@fucsalud.edu.co

Hígado graso no alcohólico en consulta de gastroenterología

Publicaciones similares